Very few hired CEOs, as opposed to founders, get this close to a billion dollars in their own company's stock. Ricks did it because he kept most of his stock while Lilly's shares rose with the success of its diabetes and obesity drugs Mounjaro and Zepbound. Here is the filing trail.
David Ricks at a glance
| Item | Figure | Date | Source |
|---|---|---|---|
| Lilly shares reported | 685,272.6 (direct, 401(k) and family trusts) | After Nov. 3, 2026 | Form 4 |
| Value of all reported shares | About $989 million | At $1,443.50, Nov. 13, 2026 | Our math |
| Value excluding family trusts | About $812 million | At $1,443.50 | Our math |
| Estimated net worth | About $850 million to $1 billion | Nov. 2026 | Our estimate |
| 2025 pay | $36,698,337 | 2025 | 2026 proxy via Equibles and Fierce Pharma |
| Pay ratio | About 293 to 1 | 2025 | Proxy via Salary.com |
| Role | Chair, president and CEO | CEO since Jan. 2017 | Form 4; Wikipedia |
| Age | About 59 (born 1967) | 2026 | Wikipedia |
How many Lilly shares does David Ricks own?
His latest Form 4, filed November 4, 2026, lists every place his Lilly shares sit:
| Holder | Shares | Notes |
|---|---|---|
| Ricks, directly | 555,278.097 | After a gift of 23,538 shares on Nov. 3, 2026 |
| 401(k) | 7,337.54 | |
| David A. Ricks 2022 GRAT | 49,127 | Grantor retained annuity trust; he is trustee |
| David A. Ricks 2025 GRAT | 4,574 | He is trustee |
| David A. Ricks SLAT | 68,656 | Spousal lifetime access trust |
| Another trust | 300 | |
| Total | 685,272.6 |
He disclaims ownership of the trust shares except for his financial interest in them. GRATs and SLATs are standard estate-planning tools: a GRAT pays shares back to its creator for a set period and passes the rest to heirs, and a SLAT holds assets for a spouse. The filing shows the GRATs doing exactly that, returning 4,990 shares to him on May 14, 2026 and 2,111 shares on September 18, 2026.
His 2026 share trail
| Date | What happened | Shares | Price | Direct holding after |
|---|---|---|---|---|
| Feb. 1, 2026 | Restricted units vest | +31,932 | $0 | 547,098.167 |
| Feb. 1, 2026 | Shares withheld for tax | -14,296.654 | $1,037.15 | 532,801.513 |
| Feb. 9, 2026 | Performance award pays out | +38,913.584 | $1,044.67 | 571,715.097 |
| May 14, 2026 | Annuity payment from 2022 GRAT | +4,990 | ||
| Sept. 18, 2026 | Annuity payment from 2025 GRAT | +2,111 | ||
| Nov. 3, 2026 | Gift | -23,538 | 555,278.097 |
The February award was worth about $40.7 million at the $1,044.67 price on the filing. The November gift of 23,538 shares was worth about $33 million at early November prices, and his three 2026 Form 4s show no open-market sales.
What his shares are worth
| Lilly price | When | All 685,273 shares | Excluding trusts (562,616) |
|---|---|---|---|
| $850.51 | 52-week low | About $583 million | About $479 million |
| $1,044.67 | Feb. 9, 2026 award price | About $716 million | About $588 million |
| $1,364.73 | Close, Nov. 5, 2026 | About $935 million | About $768 million |
| $1,443.50 | Close, Nov. 13, 2026 | About $989 million | About $812 million |
| $1,460.00 | 52-week high | About $1.0 billion | About $821 million |
At the 52-week high, the shares he and his family trusts hold briefly passed $1 billion. Lilly's stock was up about 41% over the year to mid-November 2026.
How I get to $850 million to $1 billion
The low end counts his own shares (about $812 million) plus some cash from 10 years of salary and bonus. The high end adds the family trusts, which are mostly for his heirs and spouse. He has other assets I cannot see, and he will owe tax on stock when he sells, so I give a range rather than a single figure.
David Ricks salary and pay
| Year | Salary | Stock awards | Total | Source |
|---|---|---|---|---|
| 2025 | $1.7 million | $23.3 million | $36,698,337 | 2026 proxy via BioSpace and Equibles |
| 2024 | $29,242,926 | Equibles | ||
| 2023 | $26.6 million | Fierce Pharma | ||
| 2017 (first year as CEO) | $14.4 million | Indianapolis Business Journal |
Lilly raised his annual cash bonus target from 150% to 175% of salary, according to Fierce Pharma. His pay has risen about two and a half times since his first year as CEO, while Lilly's stock price has risen much more.
David Ricks net worth and career timeline
- 1967
Born
- 1990
Graduates from Purdue University
- 1996
Earns an MBA at Indiana University's Kelley School; joins Lilly as a business development associate
- 2000s
Runs Lilly's operations in Canada and China, then Lilly USA
- 2012
Becomes president of Lilly Bio-Medicines
- Jan. 2017
Becomes CEO
- June 2017
Becomes board chair
- 2023
Total pay
- 2024
Total pay
- 2025
Total pay
- Feb. 9, 2026
Receives 38,914 performance shares
- Nov. 3, 2026
Gives away 23,538 shares; reports 685,273 shares in total
- Nov. 13, 2026
Lilly closes at $1,443.50
Who is David Ricks?
Ricks studied at Purdue, earned an MBA at Indiana University and joined Eli Lilly in Indianapolis in 1996 as a business development associate. He spent the next two decades in sales, marketing and country management, running Lilly's businesses in Canada and China and then Lilly USA, the company's largest unit. In 2012 he became president of Lilly Bio-Medicines, and he took over as CEO in January 2017 and as chair that June.
His tenure has been defined by the GLP-1 drugs tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss. Demand for them turned Lilly into the world's most valuable drugmaker and drove its market value past $1 trillion, according to BioSpace. Ricks sits on Adobe's board and Purdue's board of trustees, and he is a distinguished Eagle Scout.
Frequently asked questions
What is David Ricks's net worth?
About $850 million to $1 billion by our estimate. The 685,273 Lilly shares on his November 2026 Form 4, including family trusts, were worth about $989 million at the November 13 close.
How much does the Eli Lilly CEO make?
$36,698,337 in 2025, including a salary of about $1.7 million and about $23.3 million in stock awards.
How many Lilly shares does David Ricks own?
555,278 directly and 7,338 in his 401(k), plus 122,657 in family trusts, after his November 3, 2026 Form 4.
Is David Ricks a billionaire?
Not quite. His reported Lilly shares briefly topped $1 billion at Lilly's 52-week high, but excluding family trusts his own shares were worth about $812 million in mid-November 2026.
How old is David Ricks?
About 59. He was born in 1967.
Sources & methodology
Observations retain their source, period and definition. Uncertainty is preserved; missing values are not zero.
- Eli Lilly Form 4, David A. Ricks, filed Nov. 4, 2026 (SEC EDGAR) ↗
SEC EDGAR · 2026-11-04T00:00:00.000Z
- Eli Lilly Form 4, David A. Ricks, filed Feb. 11, 2026 (SEC EDGAR) ↗
SEC EDGAR · 2026-02-11T00:00:00.000Z
- Eli Lilly Form 4, David A. Ricks, filed Feb. 3, 2026 (SEC EDGAR) ↗
SEC EDGAR · 2026-02-03T00:00:00.000Z
- Lilly rewards CEO David Ricks with $36.7M pay package for 2025 (Fierce Pharma) ↗
Fierce Pharma
- The top 5 highest paid pharma CEOs in 2025 (BioSpace) ↗
BioSpace
- Eli Lilly executive compensation table (Equibles) ↗
Equibles
Accessed 2026-11-17.
- Ricks makes $14.4 million in first year as Eli Lilly CEO (Indianapolis Business Journal) ↗
Indianapolis Business Journal
- Eli Lilly (NY:LLY) quote (FinancialContent) ↗
FinancialContent · 2026-11-13T00:00:00.000Z
- Eli Lilly price moves (Kalkine) ↗
Kalkine
- David A. Ricks (Wikipedia) ↗
Wikipedia
Accessed 2026-11-17.
